353 related articles for article (PubMed ID: 23798459)
21. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
22. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.
Gregg LP; Hedayati SS; Yang H; Van Buren PN; Banerjee S; Navaneethan SD; Virani SS; Winkelmayer WC; Alvarez CA
Hypertension; 2021 Mar; 77(3):948-959. PubMed ID: 33423525
[TBL] [Abstract][Full Text] [Related]
23. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
24. Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.
Ku E; Ix JH; Jamerson K; Tangri N; Lin F; Gassman J; Smogorzewski M; Sarnak MJ
J Am Soc Nephrol; 2018 Sep; 29(9):2401-2408. PubMed ID: 30006417
[TBL] [Abstract][Full Text] [Related]
25. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
[TBL] [Abstract][Full Text] [Related]
26. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH
Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500
[TBL] [Abstract][Full Text] [Related]
27. SPRINT and the Kidney: What Have We Learned?
Wells R; Rahman M
Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213
[TBL] [Abstract][Full Text] [Related]
28. Intensive blood pressure control for patients aged over 60: A meta-analysis of the SPRINT, STEP, and ACCORD BP randomized controlled trials.
Li X; Zhang J; Xing Z; Liu Q; Zhou S; Xiao Y
Maturitas; 2023 Jun; 172():52-59. PubMed ID: 37099984
[TBL] [Abstract][Full Text] [Related]
29. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
30. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan.
Nagai K; Yamagata K; Iseki K; Moriyama T; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kasahara M; Shibagaki Y; Asahi K; Watanabe T
PLoS One; 2019; 14(12):e0225812. PubMed ID: 31800605
[TBL] [Abstract][Full Text] [Related]
32. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
[TBL] [Abstract][Full Text] [Related]
33. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
[TBL] [Abstract][Full Text] [Related]
34. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
35. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
36. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
37. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
38. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
[TBL] [Abstract][Full Text] [Related]
39. The role of arterial hypertension in the progression of non-diabetic glomerular diseases.
Ljutić D; Kes P
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v28-30. PubMed ID: 12817064
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
Jafar TH; Schmid CH; Landa M; Giatras I; Toto R; Remuzzi G; Maschio G; Brenner BM; Kamper A; Zucchelli P; Becker G; Himmelmann A; Bannister K; Landais P; Shahinfar S; de Jong PE; de Zeeuw D; Lau J; Levey AS
Ann Intern Med; 2001 Jul; 135(2):73-87. PubMed ID: 11453706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
